A detailed history of Momentum Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Momentum Advisors, LLC holds 6,071 shares of AZN stock, worth $391,215. This represents 0.43% of its overall portfolio holdings.

Number of Shares
6,071
Previous 6,073 0.03%
Holding current value
$391,215
Previous $333,000 23.42%
% of portfolio
0.43%
Previous 0.37%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$54.21 - $70.44 $108 - $140
-2 Reduced 0.03%
6,071 $411,000
Q3 2022

Nov 10, 2022

BUY
$53.02 - $135.75 $321,990 - $824,409
6,073 New
6,073 $333,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $200B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Momentum Advisors, LLC Portfolio

Follow Momentum Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Momentum Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Momentum Advisors, LLC with notifications on news.